Anixa Biosciences is trading at $3.31, up 13.06% in pre-market on October 1, with no clear catalyst identified. - This compares with the September 30 close of $2.93, according to supplied price context. - No company announcement dated October 1 clearly explains the move. The latest identified company news was a September 21 Australian patent announcement, which does not establish a direct connection. - Broader market indicators are mixed, and no trading-volume information was provided.